• Return to Headlines

Regeneron Pharm Down 24.8% Since SmarTrend Downtrend Call (REGN)

By Nick Russo

SmarTrend identified a Downtrend for Regeneron Pharm (NASDAQ:REGN) on March 8th, 2019 at $403.55. In approximately 3 months, Regeneron Pharm has returned 24.79% as of today's recent price of $303.52.

In the past 52 weeks, shares of Regeneron Pharm have traded between a low of $281.89 and a high of $445.00 and are now at $303.52, which is 8% above that low price. In the last five trading sessions, the 50-day moving average (MA) has fallen 1.1% while the 200-day MA has slid 0.2%.

Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company. The Company discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. Regeneron Pharmaceuticals serves the healthcare sector in the United States.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Regeneron Pharm.

Log in and add Regeneron Pharm (REGN) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights regeneron pharm

Ticker(s): REGN